Computerized measurement of LDL particle size in human serum: Reproducibility studies and evaluation of LDL particle size in relation to metabolic variables and the occurrence of atherosclerosis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 8, 1999, Pages 649-661

  Hulthe, Johannes ^a   Wiklund, O ^a   Olsson, G ^a   Fagerberg, B ^a   Bokemark, L ^a   Nivall, S ^b   Wikstrand, J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Intima media thickness; LDL particle size; Plaque occurrence

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; LIPOPROTEIN METABOLISM; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033367699     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185157     Document Type: Article

References (33)

1. 1 Slyper AH, Zvereva S, Schectman G, Hoffman RG, Walker JA. Low-density lipoprotein particle size is not a discriminating marker for atherogenic risk in male offspring of parents with early coronary artery disease. Metabolism 1997; 46: 954-8.
2. 2 Austin M, Breslow JL, Hennekens CH, Buring E, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-21.
3. 3 Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12: 187-95.
4. 4 Campos H, Roederer GO, Lussier-Cacan S, Davignon J, Krauss RM. Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease. Arterioscler Thromb Vasc Biol 1995; 15: 1043-8.
5. 5 Krauss RM. Low-density lipoprotein subclasses and risk of coronary artery disease. Curr Opin Lipidol 1991; 2: 248-52.
6. 6 Mykkänen L, Haffner SM, Rainwater DL, Karhapää P, Miettinen H, Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol 1997; 17: 1447-53.
7. 7 Slyper AH, Zvereva S, Schectman G, Hoffman RG, Mueller RA, Walker JA. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism 1997; 46: 1275-80.
8. 8 Austin MA, Mykkänen L, Kuusisto J, Edwards K, Nelson C, Haffner SM, Pyörälä K, Laakso M. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 1995; 92: 1770-8.
9. 9 Singh A, Rainwater DL, Haffner SM, VandeBerg JL, Shelledy WR, Moore Jr PH, Dyer TD. Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol 1995; 15: 1805-11.
10. 10 Sobenin IA, Tertov VT, Orekhov AN. Atherogenic modified LDL in diabetes. Diabetes 1996; 45 Suppl: S35-9.
11. 11 Lahdenperä S, Syvänne M, Kahri J, Taskinen MR. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 1996; 39: 453-61.
12. 12 O'Brien SF, Watts GF, Playford DA, Burke V, O'Neal DN, Best JD. Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin dependent diabetes. Diabet Med 1997; 14: 974-8.
13. 13 Agevall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 1995; 26: 956-60.
14. 14 Wendelhag T, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991; 11: 565-77.
15. 15 Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 1993; 13: 1404-11.
16. 16 Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 1997; 28: 2195-200.
17. 17 Klose S, Borner K. Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA-II). J Clin Chem Clin Biochem 1978; 15: 121-30.
18. 18 Wahlefeld AW Triglycerides: determination after enzymatic hydrolysis. In: Bermeyer HU, editors. Methods of enzymatic analysis. 2nd English ed. New York: Academic Press, 1974: 18-31.
19. 19 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. 20 Maciejko JJ, Levinsson SS, Markyvech L, Smith MP, Blevins RD. New assay of apolipoproteins A-1 and B by rate nephelometry evaluated. Clin Chem 1987; 33: 2065-9.
21. 21 Johansson S, Bondjers G, Fager G, Wedel H, Tsipogianni A, Olofsson S-O, Vedin A, Wiklund O, Wilhelmsson C. Serum lipids and apolipoprotein levels in women with acute myocardial infarction. Arteriosclerosis 1988; 8: 742-9.
22. 22 Wiklund O, Angelin B, Olofsson S-O, Eriksson M, Fager G, Berglund L, Bondjers G. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolemia. Lancet 1990; 335: 1360-3.
23. 23 Lahdenperä S, Puolakka J, Pyörälä T, Luotola H, Taskinen MR. Effects of postmenopausal estrogen/ progestin replacement therapy on LDL particles: comparison of transdermal and oral treatment regimens. Atherosclerosis 1996; 122: 153-62.
24. 24 Scheffer PG, Bakker SJL, Heine RJ, Teerlink T. Measurement of low-density lipoprotein particle size by high-performance gel-filtration chromatography. Clin Chem 1997; 43: 1904-12.
25. 25 Björnheden T, Babiy A, Bondjers G, Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 1996; 123: 43-56.
26. 26 Hurt-Camejo E, Camejo G, Rosengren B, López F, Wiklund O, Bondjers G. Differential uptake of proteoglycan-selected subfractions of low-density lipoprotein by human macrophages. J Lipid Res 1990; 31: 1387-98.
27. 27 Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998; 139: 205-22.
28. 28 Hurt-Camejo E, Camejo G, Rosengren B, Lòpez F, Ahlstrom C, Fager G, Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low-density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb 1992; 12: 569-83.
29. 29 Swinkels DW, Demacker PNM, Hendriks JCM, Brenninkmeijer BJ, Stuyt PM. The relevance of protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors. Atherosclerosis 1989; 77: 59-67.
30. 30 Tornvall P, Båvenholm P, Landou C, de Faire U, Hamsten A. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88: 2180-9.
31. 31 Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 1991; 90: 67-80.
32. 32 Rajman I, Kendall MJ, Cramb R, Holder RL, Slih M, Gammage MD. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridemic men. Atherosclerosis 1996; 125: 231-42.
33. 33 Williams PT, Krauss RM, Nichols AV, Vranzian KM, Wood PDS. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 1990; 31: 1131-9.